Fig. 3A, B.

Tissue to blood ratios of gamma cpm values following i.p. injection of A 150-μg ¹⁴C-peptide 101–¹²⁵I-J591 and ¹⁴C-peptide 101–¹²⁵I-DS-1 MAbs 8 days postadministration into nude mice bearing human prostate cancer LNCaP-LN3 xenografts; B 150-μg ¹⁴C-peptide 101–¹²⁵I-BLCA-38 and ¹⁴C-peptide 101–¹²⁵I-DS-1 MAb–peptide 101 conjugates 7 days postadministration into nude mice bearing human prostate cancer DU-145 xenografts. Vertical bars represent SEM (8 mice/group). BD blood, X xenograft, LU lung, LV liver, SP spleen, KD kidney, ST stomach, BL bladder, SI small intestine, LI large intestine, LN lymph node, G gonad, M muscle, SK skin, H heart, BR brain